ROYAL BANK OF CANADA - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 152 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2015. The put-call ratio across all filers is 2.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$8,792,000
+11.1%
203,472
+8.7%
0.01%
+40.0%
Q2 2015$7,911,000
+15.5%
187,187
+5.9%
0.01%0.0%
Q1 2015$6,852,000
+27.1%
176,690
+10.4%
0.01%
+66.7%
Q4 2014$5,390,000
+7.4%
160,113
+11.7%
0.00%0.0%
Q3 2014$5,018,000
+64.3%
143,289
+54.1%
0.00%
+50.0%
Q2 2014$3,055,000
+58.9%
92,969
+78.2%
0.00%
+100.0%
Q1 2014$1,922,000
-10.4%
52,163
-6.6%
0.00%
-50.0%
Q4 2013$2,145,000
+62.1%
55,851
+15.6%
0.00%
+100.0%
Q3 2013$1,323,000
+30.2%
48,300
-0.2%
0.00%0.0%
Q2 2013$1,016,00048,4000.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders